AF
ALXN

Allworth Financial’s Alexion Pharmaceuticals ALXN Stock Holding History

Allworth Financial’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-50
Closed -$5K – 1135
2019
Q3 		$5K Hold
50
– – ﹤0.01% 698
2019
Q2 		$7K Hold
50
– – ﹤0.01% 643
2019
Q1 		$7K Hold
50
– – ﹤0.01% 633
2018
Q4 		$5K Hold
50
– – ﹤0.01% 627
2018
Q3 		$7K Hold
50
– – ﹤0.01% 614
2018
Q2 		$6K Buy
+50
New +$5.84K ﹤0.01% 613
2017
Q2 		– Sell
-160
Closed -$19K – 851
2017
Q1 		$19K Hold
160
– – ﹤0.01% 373
2016
Q4 		$18K Hold
160
– – ﹤0.01% 338
2016
Q3 		$20K Hold
160
– – ﹤0.01% 332
2016
Q2 		$19K Buy
+160
New +$22.7K ﹤0.01% 318

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return